BR0211749B1 - processo para a preparação de derivados de 4-(imidazol-1- il)benzenossulfonamida - Google Patents

processo para a preparação de derivados de 4-(imidazol-1- il)benzenossulfonamida

Info

Publication number
BR0211749B1
BR0211749B1 BRPI0211749-5B1A BR0211749A BR0211749B1 BR 0211749 B1 BR0211749 B1 BR 0211749B1 BR 0211749 A BR0211749 A BR 0211749A BR 0211749 B1 BR0211749 B1 BR 0211749B1
Authority
BR
Brazil
Prior art keywords
imidazol
formula
preparation
benzenesulfonamide derivatives
chem
Prior art date
Application number
BRPI0211749-5B1A
Other languages
English (en)
Other versions
BR0211749A (pt
BRPI0211749B8 (pt
Inventor
Carmen Almansa Rosales
Concepcion Gonzalez Gonzalez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0211749A publication Critical patent/BR0211749A/pt
Publication of BR0211749B1 publication Critical patent/BR0211749B1/pt
Publication of BRPI0211749B8 publication Critical patent/BRPI0211749B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/40Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
BRPI0211749A 2001-08-07 2002-08-01 processo para a preparação de derivados de 4-(imidazol-1- il)benzenossulfonamida BRPI0211749B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200101853A ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
PCT/ES2002/000385 WO2003016285A1 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfonamida

Publications (3)

Publication Number Publication Date
BR0211749A BR0211749A (pt) 2004-10-13
BR0211749B1 true BR0211749B1 (pt) 2013-09-10
BRPI0211749B8 BRPI0211749B8 (pt) 2021-05-25

Family

ID=8498662

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0211749A BRPI0211749B8 (pt) 2001-08-07 2002-08-01 processo para a preparação de derivados de 4-(imidazol-1- il)benzenossulfonamida

Country Status (17)

Country Link
US (2) US7351836B2 (pt)
EP (1) EP1424329B1 (pt)
JP (1) JP4309262B2 (pt)
KR (1) KR100888905B1 (pt)
AR (2) AR037231A1 (pt)
AT (1) ATE396976T1 (pt)
BR (1) BRPI0211749B8 (pt)
CA (1) CA2456531C (pt)
CY (1) CY1108861T1 (pt)
DE (1) DE60226879D1 (pt)
DK (1) DK1424329T3 (pt)
ES (2) ES2184633B1 (pt)
HK (1) HK1066214A1 (pt)
MX (1) MXPA04001147A (pt)
NO (1) NO326162B1 (pt)
PT (1) PT1424329E (pt)
WO (1) WO2003016285A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2015DN00202A (pt) 2012-07-12 2015-06-12 Chiesi Farma Spa
WO2022269384A1 (en) * 2021-06-24 2022-12-29 Ami Organics Ltd. A process for the direct synthesis of fedratinib intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TNSN99111A1 (fr) * 1998-06-11 2005-11-10 Pfizer Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE69935913T2 (de) * 1998-07-02 2008-01-10 Cryptography Research Inc., San Francisco Leckresistente aktualisierung eines indexierten kryptographischen schlüssels
AR024222A1 (es) * 1998-10-16 2002-09-25 Palau Pharma Sa Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
ES2159489B1 (es) 2000-03-23 2002-04-16 Uriach & Cia Sa J Nuevos derivados de imidazol con actividad antiinflamatoria.

Also Published As

Publication number Publication date
AR086065A2 (es) 2013-11-13
KR20040020079A (ko) 2004-03-06
ES2184633A1 (es) 2003-04-01
US8476456B2 (en) 2013-07-02
MXPA04001147A (es) 2004-07-08
AR037231A1 (es) 2004-11-03
ES2307817T3 (es) 2008-12-01
JP2005502659A (ja) 2005-01-27
CY1108861T1 (el) 2014-08-13
NO326162B1 (no) 2008-10-13
KR100888905B1 (ko) 2009-03-16
CA2456531A1 (en) 2003-02-27
DE60226879D1 (de) 2008-07-10
WO2003016285A8 (es) 2003-08-28
ATE396976T1 (de) 2008-06-15
EP1424329A1 (en) 2004-06-02
WO2003016285A1 (es) 2003-02-27
EP1424329B1 (en) 2008-05-28
US7351836B2 (en) 2008-04-01
BR0211749A (pt) 2004-10-13
US20090012307A1 (en) 2009-01-08
HK1066214A1 (en) 2005-03-18
NO20040981L (no) 2004-03-05
ES2184633B1 (es) 2004-08-01
BRPI0211749B8 (pt) 2021-05-25
DK1424329T3 (da) 2008-09-29
CA2456531C (en) 2010-12-14
JP4309262B2 (ja) 2009-08-05
PT1424329E (pt) 2008-08-06
US20040242872A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
PT931788E (pt) Inibidores de metaloprotease
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
ES2172864T3 (es) 2-metoxibenzofenonas fungicidas.
NO20062644L (no) DPP-IV inhibitorer
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
DE69314456D1 (de) Arylsulfonamido-substituierte Hydroxamsäure Derivate
BR0314688A (pt) Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DE60116589D1 (de) Fungizide Phenylamidinderivative
DE69920923D1 (de) Anthranilsäurederivate
TR28332A (tr) Arilasetik asit türevleri.
ATE159728T1 (de) Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
ATE297902T1 (de) Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
BR0211749B1 (pt) processo para a preparação de derivados de 4-(imidazol-1- il)benzenossulfonamida
TR200402776T4 (tr) Nöraminik asit bileşiğinin hidratları ve bunların kristal biçimleri.
PT1165485E (pt) Processo para a preparacao de produtos intermediarios pesticidas
DE60108209D1 (de) Fungizide Phenylimidate-Derivate
BR0002512A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
BR9902096A (pt) Pitazóis.
PT1072601E (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
ATE420855T1 (de) 2-substituierte vitamin-d-derivate

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PALAU PHARMA, S.A. (ES)

Free format text: TRANSFERIDO DE: J. URIACH AND CIA. S.A.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: C07D 233/68, C07D 233/64, C07C 311/16

Ipc: C07D 233/68 (2011.01), C07D 233/64 (2011.01), C07C

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/09/2013, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/08/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 01/08/2022